Rising Electricity Prices and Scorching Heat Signal Costly Summer for Consumers US Debt Sustainability Concerns Deepen as Bond Market Selloff Intensifies Analysts Suggest Amazon UK Chief Calls for Rethinking Youth Unemployment and Education System Suze Orman Warns Retirement Healthcare Costs Are Underestimated How to Prepare UK Student Loan Inquiry Overwhelmed by 52000 Responses Highlighting Borrower Distress Tesla Launches Full SelfDriving Supervised in China Amid Intensifying Competition from Local EV Rivals OKUR Q1 2026 Earnings WiderthanExpected Loss Reflects RD Investment CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158 OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure SNCY Q1 2026 Earnings EPS Miss Weighs on Results Revenue Details Pending Landstar System LSTR Q1 2026 Earnings EPS Beats Estimates Modestly Stock Edges Higher SouthState Bank Corporation SSB Rises Modestly as Shares Hold Above Support KalVista Pharmaceuticals KALV Holds Steady Near Resistance as Investors Eye Key Catalysts Eastern International Ltd ELOG Gains Slightly Tests Key Resistance at 089 NatWest Group NWG Edges Lower on Modest Volume Support Levels Under Watch NOVONIX NVX Rises 429 as Stock Bounces from Support at 069 Bloom Energy Shares Surge on 26 Billion Data Center Deal with AI Cloud Provider Nebius BWXT Q1 2026 Earnings Strong EPS Beat Driven by Operational Excellence SoYoung International SY Plunges 165 Testing Key Support After Steep Decline CELH Q1 2026 Earnings EPS Surges 355 Above Estimates Driving Stock Higher NG Q1 2026 Earnings Narrower Loss Than Expected as Donlin Gold Project Progress Continues Qnity Electronics Inc Q Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment AutoNation Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges LIXT Q4 2024 Earnings PreRevenue Biotech Reports PerShare Loss as Stock Jumps 136